Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer

British Journal of Cancer

Volumn 71, Issue 5, 1995, Pages 1025-1028

  Duffy, M J ^a   Blaser, J ^b   Duggan, C ^a   McDermott, E ^a   O'Higgins N ^a   Fennelly, J J ^a   Tschesche, H ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

Breast cancer; Metalloprotease; MMP 8; MMP 9; TIMP 1

Indexed keywords

ESTROGEN RECEPTOR; GELATINASE B; METALLOPROTEINASE; PLASMINOGEN ACTIVATOR INHIBITOR; PROGESTERONE RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BREAST NEOPLASMS; COLLAGENASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GELATINASE B; GLYCOPROTEINS; LYMPHATIC METASTASIS; NEUTROPHIL COLLAGENASE; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0029073861     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.197     Document Type: Article

References (34)

1. ALVAREZ OA, CARMICHAEL DF, AND DECLERCK YA. (1990). Inhibition of collagenolytic activity, ANDmetastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinase. J. Natl. Cancer Inst., 82, 598–595.
2. AZNAVOORAN S, MURPHY AN, STETLER-STEVENSON WG, AND LIOTTA LA. (1993). Molecular aspects of tumor cell invasion, AND metastasis. Cancer, 71, 1368–1383.
3. BERGMANN U, MICHAELI J, OBERHOFF R, KNAUPER V, BECKMANN R, ANDTSCHESCHE H. (1989). Enzyme linked immunosorbent (ELISA) for the quantitative determination of human leukocyte collagenase, ANDgelatinase. J. Clin. Chem. Clin. Biochem., 27, 351–359.
4. BROWN PD, BLOXIDGE RE, ANDERSON E, ANDHOWELL A. (1993). Expression of activated gelatinase in human invasive breast carcinoma. Clin. Exp. Met., 11, 183–189.
5. DAI DONE MG, SILVESTRINI R, D’ERRICO A, DI FRONZO G, BENINI E, MANCINI M, GARBISA S, LIOTTA L, AND GRIGIONI W. (1991). Iminin receptors, collagenase IV, ANDprognosis in node negative breast cancers. Int. J. Cancer, 48, 529–532.
6. DAVIES B, MILES DW, HAPPERFIELD LC, NAYLOR MS, BOBROW LC, RUBENS RD, ANDBALKWILL FR. (1993). Activity of type IV collagenases in benign, AND malignant breast tissue. Br. J. Cancer, 76, 1126–1131.
7. DECLERCK YA, YEAN TD, CHAN D, SHIMADE H, ANDLANGLEY KE. (1991). Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res., 51, 2151–2157.
8. DECLERCK YA, PEREZ N, SHIMADA H, BOONE TC, LANGLEY KC, ANDTAYLOR SM. (1992). Inhibition of invasion, ANDmetastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res., 52, 701–708.
9. DUFFY MJ. (1988). Assay of estradiol, ANDprogesterone receptors in breast cancer using monoclonal antibodies. Clin. Chem., 88, 1292.
10. DUFFY MJ. (1992). The role of proteolytic enzymes in cancer invasion, ANDmetastasis. Clin. Exp. Methods., 10, 145–155.
11. DUFFY MJ. (1993). Urokinase-type plasminogen activator, ANDmalignancy. Fibrinology, 7, 295 -302.
12. DUFFY MJ, O’SIORAIN L. WALDRON B, ANDSMITH C. (1986). Estradiol receptors in human breast carcinomas assayed by use of monoclonal antibodies. Clin. Chem., 72, 1972–1974.
13. DUFFY MJ, OGRADY P, DEVANEY D, OSIORAIN L, AND FENNELLY JJ, ANDLUNEN H. (1988). Urokinase plasminogen activator, a marker for aggressive breast carcinomas. Cancer, 62, 531–533.
14. DUFFY MJ, BROUILLET JP, REILLY D, MCDERMOTT E, O HIGGINS, N, FENNELLY JJ, MAUDELANDE T, ANDROCHEFORT H. (1991). Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, ANDclinical findings. Clin. Chem., 37, 101–104.
15. GUNTHER M, HAUBECK H-D, VAN DE LEUR E, BLASER J, BENDER S. FISCHER DC, TSCHESCHE H, GREILING H, HEINRICH PC, ANDGRAEVE L. (1994). Transforming growth factor B1 regulates tissue inhibitor of metalloproteinases-1 (TIMP-1) expression in differentiated human articular chondrocytes. Arth. Rheum., 37, 395–405.
16. HASTY KA, POURMOTABBED TF, GOLDBERG GI, THOMPSON JP, SPINELLA DG, ANDSTEVENS RM. (1990). Human neutrophil collagenase. J. Biol. Chem., 265, 11421–11424.
17. HOYHTYA M, HUJANEN E, AND TURPEENUIEMI-HAJANEN T. (1990). Modulation of type IV collagenase, ANDinvasive behaviour of metastatic melanoma (A 2058) cells in vitro by monoclonal antibodies to type IV collagenase. Int. J. Cancer., 46, 282–286.
18. JANICKE F, SCHMITT M, PACHE L, ULM K, HARBECK N. HOFLER H, AND GRAEFF H. (1993). Urokinase (uPA) and its inhibitor PAI-1 are strong, ANDindependent prognostic factors in node negative breast cancer. Cancer Res. Treat., 24, 195–208.
19. KHOKHA R, WATERHOUSE P, YAGEL S, LALA P, OVERALL C, NORTON G, AND DENHARDT DT. (1989). Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science, 243, 947–950.
20. MONTEAGUDO C, MERINO MJ, SANJUAN J, LIOTTA L, AND STETLER-STE VENSON WG. (1990). Immunohistochemical distribution of type IV collagenase in normal, benign, ANDmalignant breast tissue. Am. J. Pathol., 136, 585–592.
21. MONTGOMERY A DECLERCK YA LANGLEY KE, REISFELD RA, NDMUELLER BM. (1993). Melanoma mediated dissolution of extracellular matrix: contribution of urokinase-dependent, ANDmetalloproteinase-dependent proteolytic pathways. Cancer Res., 53, 693–700.
22. OSSOWSKI L. (1992). Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, ANDinterstitial collagenase. Cancer Res., 52, 6754–6760.
23. POULSOM R, PIGNATELLI M, STETLER STE VENSON WG, LIOTTA L, WRIGHT PA JEFFERY RE. (1992). Stromal expression of 72kDa type collagenase (MMP-2) and TIMP-2 mRNA in colorectal neoplasia. Am. J. Pathol., 141, 389–396.
24. PUJOL P, MAUDELONDE T, DAURES JP, ROUANET P, BROUILLET JP, PUJOL H, ANDROCHEFORT H. (1993). A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosols. Cancer, 72, 2006–2012.
25. PYKE C, RALFKIAER E, HUHTALA P, HURSKAINEN T, DANO K, ANDTRYGGVASON K. (1992). Localisation of messenger mRNA for Mr 72,000 and 92,000 type collagenases in human skin cancers by in situ hybridisation. Cancer Res., 52, 1336–1341.
26. REILLY D, CHRISTENSEN L, DUCH M, NOLAN N, DUFFY MJ, ANDANDREASEN PA. (1992). Type-1 plasminogen activator inhibitor in human breast carcinomas. Int. J. Cancer, 50, 208–214.
27. ROCHEFORT H. (1992). Cathepsin D in breast cancer a tissue marker associated with metastasis. Eur. J. Cancer, 28A 1780–1783.
28. STAHLE-BACKDALL M, AND PARKS WC. (1993). 92-kd Gelatinase is actively expressed by eosinophils, ANDstored by neutrophils in squamous cell carcinomas. Am. J. Pathol., 142, 995–1000.
29. STEARNS ME, ANDWANG M. (1993). Type IV collagenase (Mr 72,000) expression in human prostate: benign, ANDmalignant tissue. Cancer Res., 53, 878.
30. STETLER-STEVENSON WG, KRUTZSCH HC, ANDLIOTTA LA. (1989). Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J. Biol. Chem., 264, 17374–17378.
31. URBANSKI SJ, EDWARDS DR, MAITLAND A, LECO KJ, WATSON A, ANDKOSSAKOWSKA AE. (1992). Expression of metalloproteases, ANDtheir inhibitors in primary pulmonary carcinomas. Br. J. Cancer, 66, 1188–1194.
32. WILHELM SM, COLLIER IE, MARMER BL, EISEN AZ, GRANT GA, ANDGOLDBERG GI. (1989). SV-40 transformed human lung fibroblasts secrete a 92-kDa type-IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem., 264, 17213–17221.
33. WOESSNER JF. (1991). Matrix metalloproteinases, ANDtheir inhibitors in connective tissue remodeling. FASEB J., 5, 2145–2154.
34. ZUCKER S, LYSIK RM, ZARRABI MH, ANDMOLL U. (1993). Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer, ANDbreast cancer. Cancer Res., 53, 140–146.